A virtual Who’s Who of biopharma hedge funds have stakes in a recent merger deal involving a blank-check company sponsored by a major life sciences hedge fund.Perceptive Capital Solutions Corp., a special purpose acquisition company backed by an affiliate of Joseph Edelman’s Perceptive Advisors, agreed to